158 related articles for article (PubMed ID: 30044847)
1. Zika virus as an oncolytic treatment of human neuroblastoma cells requires CD24.
Mazar J; Li Y; Rosado A; Phelan P; Kedarinath K; Parks GD; Alexander KA; Westmoreland TJ
PLoS One; 2018; 13(7):e0200358. PubMed ID: 30044847
[TBL] [Abstract][Full Text] [Related]
2. The Oncolytic Activity of Zika Viral Therapy in Human Neuroblastoma In Vivo Models Confers a Major Survival Advantage in a CD24-dependent Manner.
Mazar J; Brooks JK; Peloquin M; Rosario R; Sutton E; Longo M; Drehner D; Westmoreland TJ
Cancer Res Commun; 2024 Jan; 4(1):65-80. PubMed ID: 38214542
[TBL] [Abstract][Full Text] [Related]
3. CD24 Expression Dampens the Basal Antiviral State in Human Neuroblastoma Cells and Enhances Permissivity to Zika Virus Infection.
Kedarinath K; Fox CR; Crowgey E; Mazar J; Phelan P; Westmoreland TJ; Alexander KA; Parks GD
Viruses; 2022 Aug; 14(8):. PubMed ID: 36016357
[TBL] [Abstract][Full Text] [Related]
4. Higher Cytopathic Effects of a Zika Virus Brazilian Isolate from Bahia Compared to a Canadian-Imported Thai Strain.
Alpuche-Lazcano SP; McCullogh CR; Del Corpo O; Rance E; Scarborough RJ; Mouland AJ; Sagan SM; Teixeira MM; Gatignol A
Viruses; 2018 Jan; 10(2):. PubMed ID: 29382068
[TBL] [Abstract][Full Text] [Related]
5. Strain-Dependent Consequences of Zika Virus Infection and Differential Impact on Neural Development.
Goodfellow FT; Willard KA; Wu X; Scoville S; Stice SL; Brindley MA
Viruses; 2018 Oct; 10(10):. PubMed ID: 30304805
[TBL] [Abstract][Full Text] [Related]
6. Zika vector transmission risk in temperate Australia: a vector competence study.
Duchemin JB; Mee PT; Lynch SE; Vedururu R; Trinidad L; Paradkar P
Virol J; 2017 Jun; 14(1):108. PubMed ID: 28599659
[TBL] [Abstract][Full Text] [Related]
7. Parvovirus H1 selectively induces cytotoxic effects on human neuroblastoma cells.
Lacroix J; Leuchs B; Li J; Hristov G; Deubzer HE; Kulozik AE; Rommelaere J; Schlehofer JR; Witt O
Int J Cancer; 2010 Sep; 127(5):1230-9. PubMed ID: 20087864
[TBL] [Abstract][Full Text] [Related]
8. Anti-cancer effect of oncolytic adenovirus-armed shRNA targeting MYCN gene on doxorubicin-resistant neuroblastoma cells.
Li Y; Zhuo B; Yin Y; Han T; Li S; Li Z; Wang J
Biochem Biophys Res Commun; 2017 Sep; 491(1):134-139. PubMed ID: 28711493
[TBL] [Abstract][Full Text] [Related]
9. Infectivity of Immature Neurons to Zika Virus: A Link to Congenital Zika Syndrome.
Hughes BW; Addanki KC; Sriskanda AN; McLean E; Bagasra O
EBioMedicine; 2016 Aug; 10():65-70. PubMed ID: 27364784
[TBL] [Abstract][Full Text] [Related]
10. Oncolytic virotherapy for neuroblastoma.
Ramírez M; García-Castro J; Alemany R
Discov Med; 2010 Nov; 10(54):387-93. PubMed ID: 21122470
[TBL] [Abstract][Full Text] [Related]
11. Evaluation of anti-Zika virus activities of broad-spectrum antivirals and NIH clinical collection compounds using a cell-based, high-throughput screen assay.
Adcock RS; Chu YK; Golden JE; Chung DH
Antiviral Res; 2017 Feb; 138():47-56. PubMed ID: 27919709
[TBL] [Abstract][Full Text] [Related]
12. Virotherapy with a type 2 herpes simplex virus-derived oncolytic virus induces potent antitumor immunity against neuroblastoma.
Li H; Dutuor A; Tao L; Fu X; Zhang X
Clin Cancer Res; 2007 Jan; 13(1):316-22. PubMed ID: 17200370
[TBL] [Abstract][Full Text] [Related]
13. Zika virus infects renal proximal tubular epithelial cells with prolonged persistency and cytopathic effects.
Chen J; Yang YF; Chen J; Zhou X; Dong Z; Chen T; Yang Y; Zou P; Jiang B; Hu Y; Lu L; Zhang X; Liu J; Xu J; Zhu T
Emerg Microbes Infect; 2017 Aug; 6(8):e77. PubMed ID: 28831192
[TBL] [Abstract][Full Text] [Related]
14. Treatment of metastatic neuroblastoma with systemic oncolytic virotherapy delivered by autologous mesenchymal stem cells: an exploratory study.
García-Castro J; Alemany R; Cascalló M; Martínez-Quintanilla J; Arriero Mdel M; Lassaletta A; Madero L; Ramírez M
Cancer Gene Ther; 2010 Jul; 17(7):476-83. PubMed ID: 20168350
[TBL] [Abstract][Full Text] [Related]
15. Oncolytic poliovirus therapy and immunization with poliovirus-infected cell lysate induces potent antitumor immunity against neuroblastoma in vivo.
Toyoda H; Wimmer E; Cello J
Int J Oncol; 2011 Jan; 38(1):81-7. PubMed ID: 21109928
[TBL] [Abstract][Full Text] [Related]
16. Safe and Effective Treatment of Experimental Neuroblastoma and Glioblastoma Using Systemically Delivered Triple MicroRNA-Detargeted Oncolytic Semliki Forest Virus.
Ramachandran M; Yu D; Dyczynski M; Baskaran S; Zhang L; Lulla A; Lulla V; Saul S; Nelander S; Dimberg A; Merits A; Leja-Jarblad J; Essand M
Clin Cancer Res; 2017 Mar; 23(6):1519-1530. PubMed ID: 27637889
[No Abstract] [Full Text] [Related]
17. Oncolytic treatment and cure of neuroblastoma by a novel attenuated poliovirus in a novel poliovirus-susceptible animal model.
Toyoda H; Yin J; Mueller S; Wimmer E; Cello J
Cancer Res; 2007 Mar; 67(6):2857-64. PubMed ID: 17363609
[TBL] [Abstract][Full Text] [Related]
18. Comparative analysis of different cell systems for Zika virus (ZIKV) propagation and evaluation of anti-ZIKV compounds in vitro.
Vicenti I; Boccuto A; Giannini A; Dragoni F; Saladini F; Zazzi M
Virus Res; 2018 Jan; 244():64-70. PubMed ID: 29113824
[TBL] [Abstract][Full Text] [Related]
19. Neuroblastomas vary widely in their sensitivities to herpes simplex virotherapy unrelated to virus receptors and susceptibility.
Wang PY; Swain HM; Kunkler AL; Chen CY; Hutzen BJ; Arnold MA; Streby KA; Collins MH; Dipasquale B; Stanek JR; Conner J; van Kuppevelt TH; Glorioso JC; Grandi P; Cripe TP
Gene Ther; 2016 Feb; 23(2):135-43. PubMed ID: 26583803
[TBL] [Abstract][Full Text] [Related]
20. Influence of carrier cells on the clinical outcome of children with neuroblastoma treated with high dose of oncolytic adenovirus delivered in mesenchymal stem cells.
Melen GJ; Franco-Luzón L; Ruano D; González-Murillo Á; Alfranca A; Casco F; Lassaletta Á; Alonso M; Madero L; Alemany R; García-Castro J; Ramírez M
Cancer Lett; 2016 Feb; 371(2):161-70. PubMed ID: 26655276
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
